JP2007533728A - ウイルス感染を治療するためのhamlet(腫瘍細胞に致死的なヒトアルファ−ラクトアルブミン)の使用 - Google Patents

ウイルス感染を治療するためのhamlet(腫瘍細胞に致死的なヒトアルファ−ラクトアルブミン)の使用 Download PDF

Info

Publication number
JP2007533728A
JP2007533728A JP2007509007A JP2007509007A JP2007533728A JP 2007533728 A JP2007533728 A JP 2007533728A JP 2007509007 A JP2007509007 A JP 2007509007A JP 2007509007 A JP2007509007 A JP 2007509007A JP 2007533728 A JP2007533728 A JP 2007533728A
Authority
JP
Japan
Prior art keywords
lactalbumin
biologically active
virus
variant
genus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2007509007A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007533728A5 (cg-RX-API-DMAC10.html
Inventor
カタリーナ・スヴァンボルイ
Original Assignee
ハムレット・ファルマ・アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ハムレット・ファルマ・アーベー filed Critical ハムレット・ファルマ・アーベー
Publication of JP2007533728A publication Critical patent/JP2007533728A/ja
Publication of JP2007533728A5 publication Critical patent/JP2007533728A5/ja
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2007509007A 2004-04-20 2005-04-20 ウイルス感染を治療するためのhamlet(腫瘍細胞に致死的なヒトアルファ−ラクトアルブミン)の使用 Abandoned JP2007533728A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0408752.4A GB0408752D0 (en) 2004-04-20 2004-04-20 Therapeutic treatment
PCT/IB2005/001255 WO2005102382A1 (en) 2004-04-20 2005-04-20 Use of hamlet (human alpha-lactalbumin made lethal to tumour cells) for treating viral infections

Publications (2)

Publication Number Publication Date
JP2007533728A true JP2007533728A (ja) 2007-11-22
JP2007533728A5 JP2007533728A5 (cg-RX-API-DMAC10.html) 2008-06-05

Family

ID=32344046

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007509007A Abandoned JP2007533728A (ja) 2004-04-20 2005-04-20 ウイルス感染を治療するためのhamlet(腫瘍細胞に致死的なヒトアルファ−ラクトアルブミン)の使用

Country Status (6)

Country Link
US (1) US20070232550A1 (cg-RX-API-DMAC10.html)
EP (1) EP1765383A1 (cg-RX-API-DMAC10.html)
JP (1) JP2007533728A (cg-RX-API-DMAC10.html)
CN (1) CN1980688A (cg-RX-API-DMAC10.html)
GB (1) GB0408752D0 (cg-RX-API-DMAC10.html)
WO (1) WO2005102382A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113855787A (zh) * 2020-06-30 2021-12-31 北京大学 乳清蛋白作为冠状病毒广谱抑制剂的用途
CN120860183A (zh) * 2021-08-31 2025-10-31 合生元(广州)健康产品有限公司 用于抑制冠状病毒的组合物及其应用
CN113827707B (zh) * 2021-09-30 2023-12-05 北京大学 a-乳白蛋白在抑制冠状病毒中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment

Also Published As

Publication number Publication date
US20070232550A1 (en) 2007-10-04
WO2005102382A1 (en) 2005-11-03
EP1765383A1 (en) 2007-03-28
GB0408752D0 (en) 2004-05-26
CN1980688A (zh) 2007-06-13

Similar Documents

Publication Publication Date Title
RU2012136221A (ru) Доставка активных веществ
JP5575639B2 (ja) 改善された特性を有する再構成サーファクタント
CN1094642A (zh) 治疗组合物
JP5970465B2 (ja) ペプチドおよびウイルス・ノイラミニダーゼ阻害剤を含んでなる組成物
JP4428924B2 (ja) 生体におけるエリトロポエチンによる化学療法誘発毒性の改善方法
ATE460155T1 (de) Pharmazeutische zusammensetzung mit lyophilisiertem rekombinantem faktor viii ohne albumin als stabilisator
AU2005268755B2 (en) Composition comprising a pulmonary surfactant and a TNF-derived peptide
CN111163792A (zh) 用于治疗病毒感染的肽
CN101848727A (zh) 脱铁乳铁蛋白组合物及其用于治疗病毒性丙型肝炎的方法
US20070232550A1 (en) Use of Hamlet (Human Alpha-Lactalbumin Made Lethal to Tumour Cells) for Treating Viral Infections
ES2758674T3 (es) Uso de taurina en la prevención y/o tratamiento de enfermedades inducidas por los virus del género coronavirus y/o del género rotavirus
BR102019014292A2 (pt) Composição compreendendo inibidor de proteinase alfa-1 altamente concentrado e método de obtenção da mesma
BR112019026336A2 (pt) forma de sal de cloridrato de um peptídeo análogo da porção c-terminal de c5a e o uso da mesma, composição, método para induzir uma resposta imune contra uma infecção ou câncer, kit e composto para aumentar uma resposta imune para um agente imunogênico
JP2006500321A (ja) α−ラクトアルブミン(HAMLET)および補因子の活性複合体
KR20070070154A (ko) 애큐오린 함유 조성물 및 이를 사용하는 방법
AU2013231936B2 (en) Protein to promote blood vessel growth and uses thereof
DK2504006T3 (en) FORMATIONS COMPREHENSIVE AMINO FOR THE TREATMENT OF CHRONIC obstructive pulmonary disease
JPH09500887A (ja) ウイルス病を治療するためのチオール化合物の使用
ES2260794T3 (es) Estimulacion de los mecanismos de defensa del huesped contra los tumores.
JP2007524708A5 (cg-RX-API-DMAC10.html)
JP4541642B2 (ja) 肺感染症および肺腫瘍を治療するためのリポペプチド類およびリポプロテイン類の使用
JP2007161702A (ja) 水性吸入用医薬組成物
JP2004529158A5 (cg-RX-API-DMAC10.html)
Lee Growth factors in oral and maxillofacial surgery: potentials and challenges
JP2007533728A5 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080415

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080415

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20090318